EFNA3 and gastric adenocarcinoma: Similarly, EFNA3 mRNA levels were consistently elevated in most cancers, such as BRCA, bladder urothelial carcinoma (BLCA), cervical squamous cell carcinoma and endocervical adenocarcinoma (CESC), CHOL, COAD, esophageal carcinoma (ESCA), kidney renal clear cell carcinoma (KIRC), KIRP, liver hepatocellular carcinoma (LIHC), LUAD, LUSC, PAAD, STAD, READ, thyroid carcinoma (THCA), and uterine corpus endometrial carcinoma (UCEC), compared to adjacent normal tissues.